Ainos, Inc.
NCM: AIMDLive Quote
📈 ZcoreAI Score
Our AI model analyzes Ainos, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get AIMD Z-Score →About Ainos, Inc.
Technology
Scientific & Technical Instruments
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.
📊 Fundamental Analysis
Ainos, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -128.0%, which indicates that capital utilization is currently under pressure.
At a current price of $1.62, AIMD currently trades near the bottom of its 52-week range (11%), indicating potential value or weakness (Range: $1.26 - $4.50).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$11.77M
Trailing P/E
--
Forward P/E
--
Beta (5Y)
2.32
52W High
$4.50
52W Low
$1.26
Avg Volume
662K
Day High
Day Low